Background: Anemia will negatively affect cerebral collaterals and penumbra. Eventually, it may cause worse clinical outcomes and even increase mortality rates in stroke patients. Anemia has recently been suggested to be an independent risk factor for ischemic stroke. Therefore, we aimed to investigate the effects of the presence of anemia on clinical outcomes in ischemic stroke patients undergoing mechanical thrombectomy. Methods: This was a retrospective study involving the prospectively and consecutively collected data of 90 adult patients between January 2015 and August 2016. Hemoglobin (Hb) cutoff levels were accepted as 12 g/dL for women and 13 g/dL for men. Patients having anemia were further divided into three subgroups as severe anemia (Hb <8 g/dL for both genders), moderate anemia (Hb <10 g/dL for both genders), and mild anemia (Hb <13 g/dL for men and Hb <12 g/dL for women). Results: Forty of the subjects (44.4%) had anemia. Moderate anemia was detected in 14 out of 90 patients (15.5%) and severe anemia was found in only four of them (4.4%). Poor functional outcome (mRS 3-6) was similar in both anemic and non-anemic patients (37.5% vs. 38%, respectively, p = 0.08), but poor functional outcome was found to be statistically significant with severe anemic group (Hb <8 mg/dL) (p = 0.003). In multiple logistic regression analysis, moderate and severe anemia has been found to increase the mortality (p = 0.032). Conclusions: Our study demonstrated a poor functional outcome only in moderate to severe anemic patients. Clinicians should keep in mind the negative effect of moderate to severe anemia in the clinical course of acute stroke patients treated with mechanical thrombectomy.
Introduction
Anemia is reported in up to 40% of patients with acute ischemic stroke (AIS) [1] [2] [3] [4] . Recent clinical studies revealed that anemia seems to be significantly related with poor clinical outcome and mortality in AIS patients. Moreover, anemia has been suggested to be an independent risk factor for stroke [3, [5] [6] [7] [8] . Although anemia is not widely accepted as a traditional risk factor like hypertension, diabetes, hyperlipidemia, and smoking for ischemic stroke, it is generally evaluated as an additional and modifiable risk factor [8] . In order to supply sufficient oxygen to cerebral tissue, hemoglobin (Hb) and hematocrit (Htc) levels should be kept within normal ranges [9] . In ischemic stroke patients with anemia, oxygen supply is extremely important for increased metabolic requirements of penumbral tissue [10, 11] . Cerebral tissue oxygen requirement is regulated by cerebral autoregulation mechanism in anemic healthy patients with Hb levels up to 8 mg/dL [7] .
Nevertheless, in case of severe anemia (especially in patients with Hb levels between 5 and 7 mg/dL), blood oxygen transport capacity is reported to be markedly decreased because of the lack of sufficient cerebral arterial vasodilatation response [10, 11] . For this reason, toleration of anemia becomes much more difficult particularly in AIS patients [10, 11] . This autoregulation process is more complicated in AIS patients with anemia compared with healthy anemic patients, and the tolerable cutoff level of Hb may likely be different in this patient group [6, 8] . However, the effects of anemia on clinical and functional outcomes in ischemic stroke patients undergoing mechanical thrombectomy had not been studied previously. The mechanism of effect of anemia for acute stroke is probably similar but the important point is that there is less time for the operator for maintaining reperfusion of salvageable brain tissue at risk in anemic patients due to insufficient oxygen transport capacity. Therefore, we aimed to investigate the probable effects of anemia on the clinical outcomes of AIS patients after 3 months from the intervention.
Methods

Study Design
This was a retrospective study involving the prospectively collected data of 90 consecutive adult acute stroke patients (44 men, 46 women) who were admitted to the Interventional Neurology Unit of Ankara Numune Education and Research Hospital with intracranial large arterial occlusions and who had undergone mechanical thrombectomy between January 2015 and August 2016. This study was approved by the institutional research ethics board and the Samsun Training and Research Ethics Committee (21/02/2017-2017/3). Written consent was obtained from the patients or the relatives of the patient in the study.
Patient Characteristics
Age, gender, risk factors (hypertension, diabetes mellitus, alcohol consumption, smoking status, atrial fibrillation, coronary artery disease, congestive heart failure, previous stroke history), National Institutes of Health Stroke Scale score at admission, Hb and Htc values, and angiographic parameters (time interval between symptom onset and recanalization procedure, collateral score, the degree of revascularization after treatment) of the patients were recorded, consecutively. The degree of revascularization after treatment was defined by mTICI classification. Successful revascularization was defined as posttreatment mTICI score 2b-3. Clinical assessments were performed at the 90th day after treatment with modified Rankin scale for assessing global disability. A good functional outcome was defined as mRS score of 0-2.
Laboratory Investigations
Hb and Htc cutoff levels were accepted as 12 g/dL and 38% for women and 13 g/dL and 42% for men, respectively [11] . Patients were divided into two groups based on their Hb levels. Patients having anemia were further divided into three subgroups as severe anemia (Hb <8 mg/dL for both genders), moderate anemia (Hb <10 g/dL for both genders), and mild anemia (Hb <13 g/dL for men and Hb <12 g/dL for women). Collected data were compared between these groups.
During the clinical follow-up, erythrocyte transfusion was performed to the patients having Hb levels below 8 g/dL in acute stage, for the rest of the anemic patients, etiologic investigation and treatment were directed according to hematology clinic consultation.
Endovascular Procedure
The endovascular procedure was performed using a femoral artery approach under local anesthesia. 40 U/kg heparin was administered after guiding sheath placement. In all cases, a triaxial system was used to deliver the stent retriever (Preset TM , Phenox GmbH, Bochum, Germany).
Statistical Analysis
All statistical analyses were performed by using Statistical Package for Social Sciences (SPSS) version 11.5 package programme (SPSS Inc., Chicago, IL, USA). Mean and standard deviation were used for the presentation of normally distributed continuous variables, and median values (minimum-maximum) were used for non-parametric continuous variables. Frequencies and percentages were used while presenting the categorical data. For variables which met parametric test conditions, Student t test and for others Mann-Whitney U test were used for two group comparisons. For the evaluation of categorical variables, chi-square (χ 2 ) test and if needed, Fisher exact test were used. Comparisons were made between anemic and non-anemic stroke patients in terms of demographics, comorbidities and laboratory characteristics on admission, poor clinical outcome and mortality (mRS = 3-6) at 3rd month after stroke onset. Furthermore, we used bivariate and multiple logistic regression analysis to determine effect on mortality. All probability values were calculated by assuming a two-sided p value of <0.05 with confidence intervals (CI) at the 95% level.
Results
Totally 90 adult acute stroke patients were enrolled in this study and 44 (48.8%) of them were male. The mean age of study population was 61.4 ± 1.2 years. We achieved to give intravenous tissue plasminogen activator (iv-tPA) treatment to 53 patients (58.8%). Mean Hb and Htc levels were 10.2 ± 1.6 g/dL and 31.8 ± 5.5% in anemic group, 14.0 ± 1.5 and 41.9 ± 4.8 in non-anemic group, respectively ( Table 1) . The characteristics of patients with anemia and non-anemia are shown in Table 1 .
Forty patients (44.4%) had anemia and the rest 50 patients (55.6%) were non-anemic. Hematocrit levels were under normal values in 59 patients (65.5%). Hemoglobin levels were found to be under 10 g/dL in 14 cases (15.5%) and below 8 g/dL in four cases (4.4%). A good functional outcome (mRS 0-2) was detected in 25 out of 40 (62.5%) anemic stroke patients and 31 out of 50 (62%) non-anemic stroke patients. When the patients were evaluated according to the subgroups based on Hb levels; a good functional outcome (mRS 0-2) could be achieved in 46.2% of patients with Hb levels below 10 g/dL; whereas it was found to be in 64.8% of the patients with Hb levels above 10 g/dL. None of the patients with Hb levels below 8 g/dL had a good functional outcome. This ratio was 52% for the patients with Hb levels above 8 g/dL.
In a multiple logistic regression analysis with mortality as dependent variable, Hb level below 10 g/dL was a significant predictor for mortality together with symptomatic hemorrhage, mTICI 1-2a recanalization and ASPECT score ≤6 independently from stroke severity, age and risk factors (p = 0.032, OR 9.07 for Hb level below 10 g/dL) ( Table 2) .
Anemic and non-anemic groups were similar regarding demographic characteristics, risk factors, successful revascularization rates (mTICI 2b-3), recanalization times. A statistical significance was found in the correlation between anemia and poor clinical outcome (mRS 3-6) only in the subgroup of patients having Hb below 8 g/dL (p = 0.003).
Time between symptom onset and groin puncture were similar in both anemic and nonanemic patients (268.1 ± 88.1 (125-420) vs. 243.7 ± 71.4 (120-380), respectively). 
Discussion
Anemia is quite frequent among AIS patients. In different series, anemia was reported in 6-40% of this patients group [2] [3] [4] 6] . Moreover it is widely suggested to be related with poor functional outcome and even with increased mortality [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Consistent with these reports, 44% of our study population was anemic. Milionis et al. [13] recently reported an investigation about short-and long-term clinical effects of anemia in AIS patients and revealed that anemic stroke patients had an increased mortality rate. In addition, when the stroke patients are assessed on the 7th day, 3rd month, and 12th month after the onset of stroke, good functional outcome was reported to be more prevalent among non-anemic patients in the same study [13] . Kellert et al. [10] (n = 217) reported worse clinical outcome and increased mortality rates at the third-month assessment in anemic AIS patients. Similarly, in two different studies conducted on larger patient populations, De Fabbro et al. [14] (n = 890) and Tanne et al. [1] (n = 859) demonstrated an increased first-year mortality rate in anemic ischemic and hemorrhagic stroke patients compared with non-anemic stroke patients. In addition, a pooled analysis of 13 cohort studies revealed a 39% increased mortality rate in anemic stroke patients compared with non-anemic ones based on some subgroup analyses. However, in contrast, a small number of clinical studies did not find any significant relation between anemia and mortality rate in stroke patients [15] [16] [17] [18] [19] .
In most of the clinical studies on ischemic stroke patients, anemia is widely defined as Hb levels below 12 g/dL for women and below 13 g/dL for men and anemia is reported to be related with poor clinical outcome and mortality based on this definition. None of the studies above classified anemia regarding its severity. In our study, we preferred to make the comparisons between three anemic subgroups and eventually we found a significant difference in terms of poor clinical outcome and mortality only in the severely anemic subgroup (Hb <8 g/ dL).
The parameters that determine the arterial oxygen content are Hb level and arterial oxygen saturation. Arterial oxygen content and blood flow together determine the amount of tissue oxygen supply. As it can be easily seen from this equation, a decrease in Hb level is directly related with a decrease in oxygen amount-reaching tissues. The mechanisms by which anemia causes poor clinical outcome in AIS patients are still not fully elucidated [20] . Cerebral vascular autoregulation in healthy anemic individuals is maintained through several mechanisms. Heart rate, cardiac output, and cerebral blood flow increase, respectively. Subsequently, cerebral vasodilatation occurs and following elevated nitric oxide levels, cerebral blood flow increases. Eventually, continuous oxygen supply to cerebral arteries is maintained. After an ischemic stroke, oxygen transport capacity through the pial collaterals to penumbra and surrounding oligemic area is tried to be maintained with a cerebral autoregulation system [10] . In healthy anemic individuals, although anemic hypoxia can be tolerated up to Hb levels of 5-7 g/dL, the best toleration occurs at a Hb level of approximately 8 g/dL. Maximal cerebral vasodilatation may occur up to this level [20] . Especially at Hb levels below 5-7 g/dL, progressive tissue hypoxia and brain dysfunction begin to develop.
In anemic ischemic stroke patients, particularly in the presence of impaired vital parameters or in the presence of concomitant risk factors, the toleration cutoff for Hb level may change. Therefore, these patients become more sensitive to anemic hypoxia [20] [21] [22] . Low oxygen content of collateral flow cannot maintain tissue viability and cannot provide for metabolic requirements of penumbral area. Oxygen demand of penumbral tissue and oligemic areas cannot be met and as a result, penumbral infarct develops, and poor clinical outcome and mortality rate will increase [23] . Consistently, animal studies also confirm the fact that anemic hypoxia aggravates primary neurologic injury [24, 25] . However, in clinical practice, either the optimal Hb or Htc value to provide the penumbral area for increased oxygen demand or minimum tolerable Hb level in anemic AIS patients are not clear yet.
Although successful recanalization was achieved, there were no additional risk factors other than hypertension and there was a short time between symptom onset and recanalization; the clinical outcomes of 3 out of 4 of our cases were bad (mRS 6). Although clear-cut conclusions cannot be made from our results because of the small sample size, we suggest that in anemic AIS patients, especially with proximal vessel occlusion and Hb <8-10 g/dL, cerebral autoregulation probably becomes insufficient for the increased metabolic demands of penumbral area and eventually anemia most likely aggravates the hypoxic injury. In addition, as our study demonstrated a poor functional outcome in moderate to severe anemic patients, we suggest that mechanical thrombectomy may result in poor functional outcome as well as mortality in the severely anemic AIS patients. Clinicians should keep this in mind during performing mechanical thrombectomy. Further studies with a larger number of patients and prospective design are needed to confirm these results.
Our study has several limitations. First of all, as the sample size was rather small, it would need to be larger for convincing statistical significance. We described that all 4 patients with severe anemia had died until 10 days after stroke onset, so the causes of death were unclear. We think the causes of death were underlying disease of severe anemia that most likely aggravates the hypoxic brain injury.
Conclusion
Our study demonstrated a poor functional outcome only in moderate to severe anemic patients. Based on these findings, we suggest that mechanical thrombectomy may result with poor functional outcome as well as mortality in the severely anemic stroke patients. Clinicians should keep in mind the negative effect of moderate to severe anemia in clinical course of acute stroke patients treated with mechanical thrombectomy.
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